Nevertheless, IDH1 or IDH2 mutations in codons 132 and 140, respectively, were found in over 10% of a cohort of CN pediatric AML mostly in combination with alterations of KMT2A, NUP98, and FLT3-ITD or RAS (52). This evidence concerns the gene IDH2 and acute myeloid leukemia.